<SEC-DOCUMENT>0000920465-19-000092-index.html : 20190701
<SEC-HEADER>0000920465-19-000092.hdr.sgml : 20190701
<ACCEPTANCE-DATETIME>20190701181130
ACCESSION NUMBER:		0000920465-19-000092
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190628
FILED AS OF DATE:		20190701
DATE AS OF CHANGE:		20190701

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Wellinghoff Darryl
		CENTRAL INDEX KEY:			0001770350

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		19934581

	MAIL ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wf-form4_156201907506715.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wf-form4_156201907506715.html

Document 1 - RAW XML: wf-form4_156201907506715.xml

</DOCUMENT>
</SEC-DOCUMENT>